Skip to main content
SpringerLink
Log in

A genetic approach to select and validate new targets for treatment of rheumatic diseases

  • Chapter
Book cover The Hereditary Basis of Rheumatic Diseases

Part of the book series: Progress in Inflammation Research ((PIR))

  • 526 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85: 307–310

    Article  PubMed  CAS  Google Scholar 

  2. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356–361

    Article  PubMed  CAS  Google Scholar 

  3. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358: 903–911

    Article  PubMed  CAS  Google Scholar 

  4. Bannwarth B, Labat L, Moride Y, Schaeverbeke T (1994) Methotrexate in rheumatoid arthritis. An update. Drugs 47: 25–50

    Article  PubMed  CAS  Google Scholar 

  5. Pincus T, Marcum SB, Callahan LF (1992) Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol 19: 1885–1894

    PubMed  CAS  Google Scholar 

  6. Franklin CM (1999) Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis. Semin Arthritis Rheum 29: 172–181

    Article  PubMed  CAS  Google Scholar 

  7. Antoni C, Kalden JR (1999) Combination therapy of the chimeric monoclonal antitumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis. Clin Exp Rheumatol 17: S73–77

    PubMed  CAS  Google Scholar 

  8. Watt I, Cobby M (2001) Treatment of rheumatoid arthritis patients with interleukin-1 receptor antagonist: radiologic assessment. Semin Arthritis Rheum 30: 21–25

    Article  PubMed  CAS  Google Scholar 

  9. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martin Mola E, Pavelka K, Sany J, Settas L et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363: 675–681

    Article  PubMed  CAS  Google Scholar 

  10. Symmons DP, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG, Silman AJ (1997) Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary carebased incident case-control study in Norfolk, England. Arthritis Rheum 40: 1955–1961

    PubMed  CAS  Google Scholar 

  11. Aho K, Koskenvuo M, Tuominen J, Kaprio J (1986) Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13: 899–902

    PubMed  CAS  Google Scholar 

  12. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43: 30–37

    Article  PubMed  CAS  Google Scholar 

  13. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WE (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32: 903–907

    PubMed  CAS  Google Scholar 

  14. Seldin MF, Amos CI, Ward R, Gregersen PK (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 42: 1071–1079

    Article  PubMed  CAS  Google Scholar 

  15. Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ (1999) Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42: 1339–1346

    Article  PubMed  CAS  Google Scholar 

  16. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al (2001) Initial sequencing and analysis of the human genome. Nature 409: 860–921

    Article  PubMed  CAS  Google Scholar 

  17. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA et al (2001) The sequence of the human genome. Science 291:1304–1351

    Article  PubMed  CAS  Google Scholar 

  18. Foster MW, Sharp RR (2004) Beyond race: towards a whole-genome perspective on human populations and genetic variation. Nat Rev Genet 5: 790–796

    Article  PubMed  CAS  Google Scholar 

  19. John S, Eyre S, Myerscough A, Barrett J, Silman A, Ollier W, Worthington J (2001) Linkage and association analysis of candidate genes in rheumatoid arthritis. J Rheumatol 28: 1752–1755

    PubMed  CAS  Google Scholar 

  20. Scott DL (2003) Genotypes and phenotypes: should genetic markers and clinical predictors drive initial treatment decisions in rheumatic diseases? Curr Opin Rheumatol 15:213–218

    Article  PubMed  CAS  Google Scholar 

  21. Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C et al (2004) DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets Genes Immun 5: 597–608

    Article  PubMed  CAS  Google Scholar 

  22. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW (1997) Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94: 2150–155

    Article  PubMed  CAS  Google Scholar 

  23. Lanchbury J, Hall M, Steer S (2002) Progress and problems in defining susceptibility genes for rheumatic diseases. Rheumatology (Oxford) 41: 361–364

    Article  PubMed  CAS  Google Scholar 

  24. Jarvis JN, Centola M (2005) Gene-expression profiling: time for clinical application? Lancet 365: 199–200

    PubMed  Google Scholar 

  25. Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J, Aune TM (2004) A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis 63: 1387–1392

    Article  PubMed  CAS  Google Scholar 

  26. Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847–856

    Article  PubMed  CAS  Google Scholar 

  27. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C et al (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76–80

    Article  PubMed  CAS  Google Scholar 

  28. Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36: 178–182

    Article  PubMed  CAS  Google Scholar 

  29. Weyand CM, Goronzy JJ (2000) Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res 2: 212–216

    Article  PubMed  CAS  Google Scholar 

  30. Cornelis F, Faure S, Martinez M, Prud’homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A et al (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 95: 10746–10750

    Article  PubMed  CAS  Google Scholar 

  31. Hardwick LJ, Walsh S, Butcher S, Nicod A, Shatford J, Bell J, Lathrop M, Wordsworth BP (1997) Genetic mapping of susceptibility loci in the genes involved in rheumatoid arthritis. J Rheumatol 24: 197–198

    PubMed  CAS  Google Scholar 

  32. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL et al (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 68: 927–936

    Article  PubMed  CAS  Google Scholar 

  33. MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S et al (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639

    Article  PubMed  CAS  Google Scholar 

  34. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M (2001) Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 69: 936–950

    Article  PubMed  CAS  Google Scholar 

  35. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, Allahabadia A, Franklyn JA, Tuomilehto J, Tuomilehto-Wolf E et al (2002) Parameters for reliable results in genetic association studies in common disease. Nat Genet 30: 149–150

    Article  PubMed  CAS  Google Scholar 

  36. Morahan G, Morel L (2002) Genetics of autoimmune diseases in humans and in animal models. Curr Opin Immunol 14: 803–811

    Article  PubMed  CAS  Google Scholar 

  37. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE et al (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163–175

    Article  PubMed  CAS  Google Scholar 

  38. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V et al (2002) CARD15/NOD2 mutational analysis and genoty-pephenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70: 845–857

    Article  PubMed  CAS  Google Scholar 

  39. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdottir H, Grondal G et al (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 28: 28

    Google Scholar 

  40. Rannala B (2001) Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics 1: 203–221

    Article  PubMed  CAS  Google Scholar 

  41. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B (1980) Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666–668

    Article  PubMed  CAS  Google Scholar 

  42. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 146: 857–868

    Article  PubMed  CAS  Google Scholar 

  43. Lu S, Carlsen S, Hansson AS, Holmdahl R (2002) Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen. J Autoimmun 18: 199–211

    Article  PubMed  Google Scholar 

  44. Carlsen S, Hansson AS, Olsson H, Heinegard D, Holmdahl R (1998) Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 114:477–484

    Article  PubMed  CAS  Google Scholar 

  45. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R (1992) Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 76: 197–202

    PubMed  CAS  Google Scholar 

  46. Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Wester L, Holmberg J, Pettersson U (2001) Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 184: 184–202

    Article  PubMed  CAS  Google Scholar 

  47. Lorentzen JC (1999) Identification of arthritogenic adjuvants of self and foreign origin. Scand J Immunol 49: 45–50

    Article  PubMed  CAS  Google Scholar 

  48. Pearson CM (1956) Development of arthritis, periarthritis and perioscitis in rats given adjuvants. Proc Soc Exp Biol Med 91: 91–101

    Google Scholar 

  49. Vingsbo C, Jonsson R, Holmdahl R (1995) Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99: 359–363

    Article  PubMed  CAS  Google Scholar 

  50. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R (1996) Pristaneinduced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 149: 1675–1683

    PubMed  CAS  Google Scholar 

  51. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    PubMed  CAS  Google Scholar 

  52. Wakeland E, Morel L, Achey K, Yui M, Longmate J (1997) Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 18: 472–477

    Article  PubMed  CAS  Google Scholar 

  53. Remmers EF, Longman RE, Du Y, O’Hare A, Cannon GW, Griffiths MM, Wilder RL (1996) A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 14: 82–85

    Article  PubMed  CAS  Google Scholar 

  54. Jirholt J, Cook A, Emahazion T, Sundvall M, Jansson L, Nordquist N, Pettersson U, Holmdahl R (1998) Genetic linkage analysis of collageninduced arthritis in the mouse. Eur J Immunol 28: 3321–3328

    Article  PubMed  CAS  Google Scholar 

  55. McIndoe RA, Bohlman B, Chi E, Schuster E, Lindhardt M, Hood L (1999) Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci USA 96: 2210–2214

    Article  PubMed  CAS  Google Scholar 

  56. Holmdahl R (2003) Dissection of the genetic complexity of arthritis using animal models. J Autoimmun 21: 99–103

    Article  PubMed  CAS  Google Scholar 

  57. Griffiths MM, Remmers EF (2001) Genetic analysis of collagen-induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol Rev 184: 172–183

    Article  PubMed  CAS  Google Scholar 

  58. Holmdahl R, Bockermann R, Jirholt J, Johansson A, Olofsson P, Lu S (2001) Elucidation of pathways leading to rheumatoid arthritis by genetic analysis of animal models. Curr Dir Autoimmun 3: 17–35

    Article  PubMed  CAS  Google Scholar 

  59. Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS (2005) The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum 52: 322–332

    Article  PubMed  CAS  Google Scholar 

  60. Ribbhammar U, Flornes L, Backdahl L, Luthman H, Fossum S, Lorentzen JC (2003) High resolution mapping of an arthritis susceptibility locus on rat chromosome 4, and characterization of regulated phenotypes. Hum Mol Genet 12: 2087–2096

    Article  PubMed  CAS  Google Scholar 

  61. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33:25–32

    Article  PubMed  CAS  Google Scholar 

  62. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101:12646–12651

    Article  PubMed  CAS  Google Scholar 

  63. Jarvinen P, Aho K (1994) Twin studies in rheumatic diseases. Semin Arthritis Rheum 24:19–28

    Article  PubMed  CAS  Google Scholar 

  64. Gregersen PK (1999) Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res 1: 37–44

    Article  PubMed  CAS  Google Scholar 

  65. Kremer JM, Phelps CT (1992) Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum 35: 138–145

    PubMed  CAS  Google Scholar 

  66. Wolfe F, Michaud K, Stephenson B, Doyle J (2003) Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate. J Rheumatol 30: 1725–1732

    PubMed  CAS  Google Scholar 

  67. Alarcon GS, Tracy IC, Blackburn WD Jr (1989) Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32:671–676

    PubMed  CAS  Google Scholar 

  68. McLeod HL, Evans WE (2001) Pharmacogenomics: unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol 41: 101–121

    Article  PubMed  CAS  Google Scholar 

  69. Gulcher J, Kong A, Stefansson K (2001) The genealogic approach to human genetics of disease. Cancer J 7: 61–68

    PubMed  CAS  Google Scholar 

  70. Grant SF, Thorleifsson G, Frigge ML, Thorsteinsson J, Gunnlaugsdottir B, Geirsson AJ, Gudmundsson M, Vikingsson A, Erlendsson K, Valsson J et al (2001) The inheritance of rheumatoid arthritis in Iceland. Arthritis Rheum 44: 2247–2254

    Article  PubMed  CAS  Google Scholar 

  71. Lin JP, Hirsch R, Jacobsson LT, Scott WW, Ma LD, Pillemer SR, Knowler WC, Kastner DL, Bale SJ (1999) Genealogy construction in a historically isolated population: application to genetic studies of rheumatoid arthritis in the Pima Indian. Genet Med 1:187–193

    PubMed  CAS  Google Scholar 

  72. Mokwe E, Ohmit SE, Nasser SA, Shafi T, Saunders E, Crook E, Dudley A, Flack JM (2004) Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension 43: 1202–1207

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Arexis AB, Arvid Wallgrens Backe 20, 41346, Göteborg, Sweden

    Peter J. Olofsson

Authors
  1. Peter J. Olofsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section for Medical Inflammation Research, Department of Cell and Molecular Biology, Lund University, Solvegatan 19, I11 BMC, S-221 84, Lund, Sweden

    Rikard Holmdahl

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Olofsson, P.J. (2006). A genetic approach to select and validate new targets for treatment of rheumatic diseases. In: Holmdahl, R. (eds) The Hereditary Basis of Rheumatic Diseases. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7419-5_12

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7419-5_12

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-7201-9

  • Online ISBN: 978-3-7643-7419-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation